Gosset Ownership
Private
Therapeutic Areas
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Sharp Therapeutics General Information
Completed reverse takeover and TSXV listing; focuses on biosensor technologies/platforms for drug discovery and/or therapeutic development. No clinical results disclosed yet.
Drug Pipeline
No pipeline data available
Key Partnerships
Sharp Therapeutics Funding
No funding data available
To view Sharp Therapeutics's complete valuation and funding history, request access »